Bionano Genomics, Inc. (BNGO)
BNGO Stock Price Chart
Explore Bionano Genomics, Inc. interactive price chart. Choose custom timeframes to analyze BNGO price movements and trends.
BNGO Company Profile
Discover essential business fundamentals and corporate details for Bionano Genomics, Inc. (BNGO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
21 Aug 2018
Employees
98.00
Website
https://www.bionanogenomics.comCEO
Robert Erik Holmlin
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
BNGO Financial Timeline
Browse a chronological timeline of Bionano Genomics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$1.81, while revenue estimate is $6.88M.
Earnings released on 14 Aug 2025
EPS came in at -$1.99 surpassing the estimated -$2.69 by +26.02%, while revenue for the quarter reached $6.73M , missing expectations by -6.78%.
Earnings released on 14 May 2025
EPS came in at -$1.15 surpassing the estimated -$3.49 by +67.05%, while revenue for the quarter reached $6.46M , beating expectations by +3.31%.
Earnings released on 31 Mar 2025
EPS came in at -$57.49 falling short of the estimated -$6.00 by -858.17%, while revenue for the quarter reached $8.16M , beating expectations by +31.66%.
Stock split effective on 27 Jan 2025
Shares were split 1 : 60 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$19.16 falling short of the estimated -$0.21 by -9.02K%, while revenue for the quarter reached $6.07M , missing expectations by -3.60%.
Earnings released on 7 Aug 2024
EPS came in at -$14.37 falling short of the estimated -$0.42 by -3.32K%, while revenue for the quarter reached $7.77M , beating expectations by +23.35%.
Earnings released on 8 May 2024
EPS came in at -$35.93 falling short of the estimated -$0.64 by -5.51K%, while revenue for the quarter reached $8.77M , missing expectations by -18.21%.
Earnings released on 5 Mar 2024
EPS came in at -$57.49 falling short of the estimated -$0.87 by -6.51K%, while revenue for the quarter reached $10.72M , beating expectations by +1.33%.
Earnings released on 8 Nov 2023
EPS came in at -$88.62 falling short of the estimated -$44.91 by -97.33%, while revenue for the quarter reached $9.32M , missing expectations by -11.59%.
Earnings released on 9 Aug 2023
EPS came in at -$74.25 falling short of the estimated -$53.89 by -37.78%, while revenue for the quarter reached $8.66M , beating expectations by +4.49%.
Stock split effective on 7 Aug 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2023
EPS came in at -$71.86 falling short of the estimated -$53.89 by -33.35%, while revenue for the quarter reached $7.42M , beating expectations by +0.75%.
Earnings released on 9 Mar 2023
EPS came in at -$77.84 falling short of the estimated -$53.89 by -44.44%, while revenue for the quarter reached $8.22M , beating expectations by +2.69%.
Earnings released on 3 Nov 2022
EPS came in at -$65.87 surpassing the estimated -$71.86 by +8.34%, while revenue for the quarter reached $7.22M , beating expectations by +6.28%.
Earnings released on 4 Aug 2022
EPS came in at -$65.87 falling short of the estimated -$59.88 by -10.00%, while revenue for the quarter reached $6.67M , beating expectations by +6.16%.
Earnings released on 5 May 2022
EPS came in at -$65.87 falling short of the estimated -$47.90 by -37.52%, while revenue for the quarter reached $5.70M , missing expectations by -0.12%.
Earnings released on 1 Mar 2022
EPS came in at -$47.90 falling short of the estimated -$41.92 by -14.27%, while revenue for the quarter reached $6.30M , beating expectations by +13.09%.
Earnings released on 4 Nov 2021
EPS came in at -$41.92 falling short of the estimated -$35.93 by -16.67%, while revenue for the quarter reached $4.66M , beating expectations by +10.05%.
Earnings released on 4 Aug 2021
EPS came in at -$35.93 falling short of the estimated -$29.94 by -20.01%, while revenue for the quarter reached $3.86M , meeting expectations.
Earnings released on 13 May 2021
EPS came in at -$29.94 matching the estimated -$29.94, while revenue for the quarter reached $3.17M , meeting expectations.
Earnings released on 23 Mar 2021
EPS came in at -$35.93 matching the estimated -$35.93, while revenue for the quarter reached $3.99M .
Earnings released on 13 Nov 2020
EPS came in at -$47.90 falling short of the estimated -$35.93 by -33.31%, while revenue for the quarter reached $2.20M , beating expectations by +1.01%.
BNGO Stock Performance
Access detailed BNGO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.